Hikma inks exclusive agreement with Chiesi Farmaceutici
13th Jan 2020 09:05
(Sharecast News) - British pharmaceutical company Hikma has inked an exclusive licensing and distribution agreement with Chiesi Farmaceutici, a research-focused business headquartered in Italy.
Read moreFriday broker round-up
10th Jan 2020 12:57
(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.
Read moreHikma, Arecor to co-develop injectable medicine in US
9th Jan 2020 08:11
(Sharecast News) - Hikma Pharmaceuticals on Thursday said it had signed a deal with Arecor to co-develop a ready-to-use injectable medicine in the US.
Read moreHikma responds to FDA concerns over 'Advair Diskus' generic
27th Nov 2019 07:32
(Sharecast News) - Hikma Pharmaceuticals has submitted its response to deficiencies in its abbreviated new drug application for a generic version of GlaxoSmithKline's 'Advair Diskus', or fluticasone propionate and salmeterol inhalation powder, to the US Food and Drug Administration (FDA), it announced on Wednesday.
Read moreHikma Pharmaceuticals maintains guidance as it invests in growth
7th Nov 2019 07:49
(Sharecast News) - Hikma Pharmaceuticals updated the market on its current trading on Thursday, reporting that its global injectables business was continuing to perform well.
Read moreFTSE 250 movers: Sirius plummets, Sophos climbs
17th Sep 2019 15:02
(Sharecast News) - London's FTSE 250 was down 0.3% at 20,003.51 in afternoon trade on Tuesday, as Sirius Minerals led the index lower.
Read moreM&S faces FTSE 100 demotion for the first time
23rd Aug 2019 10:07
(Sharecast News) - Marks & Spencer is likely to drop out of the index of leading shares for the first time since the FTSE 100 was formed 35 years ago as the retailer suffers the effects of high street decline and its own problems.
Read moreHikma reports good start to 2019
17th May 2019 07:03
(Sharecast News) - Hikma Pharmaceuticals said it made a good start to 2019 with healthy demand across its businesses.
Read moreWednesday broker round-up
10th Apr 2019 13:02
(Sharecast News) - Glencore: RBC Capital Markets downgrades to sector perform with a target price of 330p.
Read moreHikma Pharmaceuticals director buys-in after full-year results
14th Mar 2019 16:24
(Sharecast News) - One of Hikma Pharmaceuticals's directors picked-up some shares in the company the day after its latest full-year numbers.
Read moreThursday broker round-up
14th Mar 2019 13:22
(Sharecast News) - Savills: Peel Hunt downgrades to hold with a target price of 925p.
Read moreHikma Pharma profits jab higher
13th Mar 2019 08:56
(Sharecast News) - Hikma Pharmaceuticals grew 2018 sales and profits much more than it had expected at the start of last year, but final numbers and guidance for 2019 from the speciality and generic drug maker were both a little short of upgraded market forecasts.
Read moreWednesday preview: WA votes in Parliament, Hikma Pharmaceuticals
12th Mar 2019 14:55
(Sharecast News) - Investors may be facing heightened volatility on Wednesday, as financial markets digest the result of Parliament's vote on Theresa May's proposal for the UK's withdrawal agreement with the European Union.
Read moreTobacco stocks rise after FDA boss Gottlieb quits
6th Mar 2019 09:20
(Sharecast News) - Shares in tobacco companies rose on Wednesday after America's chief drug and tobacco regulator unexpectedly resigned overnight.
Read moreHikma launches generic Mitomycin injection in US
29th Jan 2019 09:42
(Sharecast News) - Hikma Pharmaceuticals announced on Tuesday that its Hikma Pharmaceuticals USA division, formerly known as West-Ward Pharmaceuticals, has launched Mitomycin for Injection, USP' at dosages of 20mg and 40mg.
Read more